After surgery, many people with stage I to stage III hormone receptor-positive breast cancer take tamoxifen or an aromatase inhibitor for five to 10 years. This has been the standard of care for the last 25 years.

At the 2025 San Antonio Breast Cancer Symposium, UCLA scientist Dr. Aditya Bardia presented results on giredestrant, a new oral selective estrogen degrader/downregulator (SERD) that offered better disease-free survival — how long people live without the cancer returning – than tamoxifen or an aromatase inhibitor.

Listen to the episode to hear Dr. Bardia explain:

This bonus episode is the audio of a Breastcancer.org ⁠⁠⁠webinar.

Managing breast cancer treatment can be a long, complex process with unexpected obstacles. Some people experience a cosmetic or medical issue with their breast reconstruction that occurs soon after surgery or years later.

If you’re unhappy with the cosmetic results of reconstruction after a mastectomy or lumpectomy — or you’re feeling pain, tightness, or changes in implant position — a corrective procedure may be beneficial for you. 

In this webinar, three highly specialized breast surgeons discuss what to do when issues develop after getting implants or having a flap reconstruction – which is using your own tissue to rebuild a breast. They explain possible complications, how to find the right doctor for revision surgery, techniques to fix reconstruction issues, and paying for a corrective procedure. 

Listen to the webinar to learn about options for managing discomfort, changes in shape, size, positioning of the breast, asymmetry, implant rupture, capsular contracture, fat necrosis, and more. And remember, If you notice symptoms that concern you, it’s best to see your doctor as soon as possible and ask if what you’re experiencing is normal for the type of reconstruction you had and other health factors that are specific to you. 

Learn more about corrective breast reconstruction surgery.

Featured Speakers:

Marisa Weiss, MD
Chief Medical Officer, Breastcancer.org

Anne Peled, MD
Board-certified Plastic Surgeon 
Co-director, Breast Care Center of Excellence
Sutter Health 

Dhivya Srinivasa, MD, FACS
Double Board-certified General and Plastic Surgeon
Founder, The Institute for Advanced Breast Reconstruction

Sarosh Zafar, MD
Double Board-certified General and Plastic Surgeon
Center for Restorative Breast Surgery

Male breast cancer makes up about 1% of all breast cancer cases. The numbers are small, but it does happen. Jake Messier is living with metastatic breast cancer after first being diagnosed with stage II disease in 2023. Jake has very active Tik Tok and Instagram accounts (theguywithstage4breastcancer) detailing his experience with breast cancer.

Listen to the episode to hear Jake explain:

This bonus episode is the audio of a Breastcancer.org ⁠⁠webinar.

Hair loss. Fatigue. Forgetfulness. Vomiting. Weight changes. Neuropathy. The possible side effects of chemotherapy for breast cancer can be concerning — especially because there’s no way to predict exactly how each person will react to treatment. It can feel overwhelming to manage it all, but there are steps you can take to help yourself.

Watch this webinar to learn from experts about what to expect and how to prepare for short and long-term side effects. You’ll hear how to manage changes to your body and mind before, during, and after treatment. Get actionable advice on ways to reduce some side effects, and advocate for your care.

Learn more about breast cancer chemotherapy side effects.

Featured Speakers:

Marisa Weiss, MD
Chief Medical Officer, Breastcancer.org

Aditya Bardia, MD, MPH, FASCO
Director, Translational Research Integration at UCLA Health
Professor, Department of Medicine at UCLA Health

Maryam Lustberg, MD, MPH
Director, Breast Center at Smilow Cancer Hospital
Chief, Breast Medical Oncology at Yale Cancer Center
Associate Professor of Medicine, Yale

LaShae Rolle, MPH, CPH
Predoctoral Fellow, University of Miami
Breast Cancer Survivor

Cara Sapida
Reporter, WPXI-TV
Breast Cancer Survivor

Ashley Patrick, PharmD
Registered Manager Onsite Pharmacy, Walgreens

Dr. Andrei Goga and his colleagues found that triple-negative breast cancer cells build molecular tunnels called gap junctions into nearby fat cells and use the fat cells’ energy for fuel. When the scientists blocked the gap junctions, the tumors stopped growing.

Listen to the episode to hear Dr. Goga explain:

This bonus episode is the audio of a Breastcancer.org ⁠webinar.

For many people, life after breast cancer isn't as easy as just moving on. Physical side effects may linger, and the emotional healing is ongoing. Fear of recurrence can affect our mental health and relationships even when we are doing our best to live in the moment.

Listen to this webinar for an honest conversation between breast cancer survivors about realistically managing anxiety and stress, staying active, and finding a balanced healthy lifestyle.

You’ll also hear from medical experts about survivorship care plans, and their perspective on making healthy choices without putting too much pressure on yourself to be perfect. 

Special thanks to ArmorUp for Life for partnering with Breastcancer.org on the webinar.

Read more about getting the best follow up care for you.

Featured Speakers:

Marisa Weiss, MD
Chief Medical Officer, Breastcancer.org

Kevin Fox, MD
Emeritus Professor of Medicine, Perelman School of Medicine at University of Pennsylvania

Loriana Hernández-Aldama
Founder, ArmorUp for LIFE

Charlene Abrams
Breast Cancer Survivor and Advocate

Carolyn Teschler
Breast Cancer Survivor and Advocate

Epiphany Wallner-Haas
Breast Cancer Survivor and Advocate

After being diagnosed with breast cancer, nearly everyone worries that the cancer will come back. But for some people, this fear is overwhelming and interferes with their ability to function and live their lives.  Clinical health psychologist Dr. Shelly Johns is studying the effect fear of breast cancer recurrence has on people’s lives and how they cope with that fear. 

Listen to the episode to hear Dr. Johns discuss:

This bonus episode is the audio of a Breastcancer.org webinar.

When life is interrupted by breast cancer at a young age, there are distinct challenges and quality-of-life issues to manage. 

It’s important to understand all the possible ways a diagnosis can impact the future, including fertility decisions, pregnancy care, career disruptions, parenting young kids, long-term survivorship concerns, sexuality, and more.

This webinar is for patients, caregivers, advocates, and healthcare providers who want to understand and support the unique experiences of people diagnosed before age 45. Hear powerful personal stories, get expert insights, and learn about resources that can help you. 

Featured Speakers:

Jeanelle Adams
Breast Cancer Advocate, @elleviews

Allie Brumel
Chief Operating Officer, The Breasties

Brooks Fuentes
Community Support, Young Survival Coalition

Hayley Gullen
Author, Illustrator, and Breast Cancer Survivor

Melissa Jenkins
Community Director, Breastcancer.org

Athena Jones
Award-winning Journalist and Breast Cancer Advocate

Jasmine McDonald, PhD
Associate Professor, Columbia University

Mackenzie McGrath
VP, Programs, First Descents

Megan Tesch, MD, MPH
Breast Oncologist, Dana-Farber Cancer Institute

Dani Trops
Breast Cancer Advocate, @dani_trops

Marisa Weiss, MD
Chief Medical Officer, Breastcancer.org

According to a KFF poll, about one in eight, or 12%, of adults in the United States have used a GLP-1 medicine like Ozempic, Trulicity, Victoza, Mounjaro, Wegovy, or Zepbound. These drugs were originally developed to treat diabetes, but quickly started being prescribed for weight loss and other uses.

While they seem like wonder drugs, GLP-1 medicines do cause side effects and have risks. Nausea, vomiting, diarrhea, and constipation are common side effects. The drugs also can cause dizziness, headaches, and elevated heartbeat. 

Dr. Neil Iyengar is a breast medical oncologist who studies how diet and exercise can improve quality of life for people with breast cancer. He’s also prescribed GLP-1 medicines for the people he cares for.

Listen to the episode to hear Dr. Iyengar explain:

This is a bonus episode of the audio of a Breastcancer.org ⁠⁠⁠⁠webinar⁠⁠⁠⁠.

Triple-negative breast cancer (TNBC) is an invasive subtype of breast cancer that can be harder to treat and is more likely to come back. But new research into understanding TNBC is helping some patients find more precise treatment options. 

Learn about innovations in immunotherapy, genetic testing, and targeted therapies, why TNBC is different compared to other types of breast cancer, and what gives doctors hope about the future of care for people with TNBC.

You’ll also hear from two inspiring breast cancer advocates who created TNBC resources for patients after their own diagnosis.

Read more about triple-negative breast cancer.

Featured Speakers:

Maimah Karmo
Breast Cancer Advocate and Founder, Tigerlily

Roberto Leon-Ferre, MD
Co-Leader of the Triple-Negative Breast Cancer Working Group and Associate Professor at Mayo Clinic

Evelyn Taiwo, MD
Hematology and Oncology at New York Presbyterian Brooklyn Methodist Hospital and Associate Professor at Cornell University

Kelly Thomas
Breast Cancer Advocate and Founder, TNBC Thrivers

Marisa Weiss, MD
Chief Medical Officer, Breastcancer.org